STIM Stock Price Chart
Daily OHLCV with technical indicators — pan, zoom, and customize your view
04
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Neuronetics, Inc. - Common Stock
Company overview from Wikipedia
05 · wikidata
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration (FDA) approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device (FDA approval K061053)."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.
10-Year Performance
Revenue, net income, margins and EPS trends
06
Revenue$149M2016-12-31 → 2025-12-31
EPS$-0.592019-12-31 → 2025-12-31
Free Cash Flow$-21M2018-12-31 → 2025-12-31
Net margin-19.6%2018-12-31 → 2025-12-31
Valuation & Ratios07–12
Valuation
P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
STIM
5Y avg
Peer Median
Verdict
P/E (TTM)
-4.95Y avg ≈-3.0
≈-3.0
·
·
P/S (TTM)
1.15Y avg ≈1.6
≈1.6
3.1
Undervalued
P/B (MRQ)
9.25Y avg ≈2.9
≈2.9
3.7
Overvalued
EV / EBITDA
-6.75Y avg ≈-3.7
≈-3.7
·
·
Price / FCF (TTM)
-14.65Y avg ≈-3.8
≈-3.8
·
·
Price / Cash Flow (TTM)
-16.05Y avg ≈-4.1
≈-4.1
·
·
EV / Revenue
1.35Y avg ≈1.4
≈1.4
·
·
EV / FCF
-8.85Y avg ≈-3.8
≈-3.8
·
·
Price / Tangible Book (MRQ)
382.75Y avg ≈2.4
≈2.4
·
·
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability
Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
STIM
5Y avg
Peer Median
Verdict
Gross Margin (TTM)
49.1%5Y avg ≈69.7%
≈69.7%
51.1%
In line
Operating Margin (TTM)
-14.7%5Y avg ≈-42.7%
≈-42.7%
0.77%
Below avg
EBITDA Margin (TTM)
-12.7%5Y avg ≈-40.3%
≈-40.3%
0.77%
Below avg
Net Profit Margin (TTM)
-19.6%5Y avg ≈-48.0%
≈-48.0%
-2.9%
Weak
ROA (TTM)
-22.9%5Y avg ≈-29.0%
≈-29.0%
-18.1%
Weak
ROE (TTM)
-135.3%5Y avg ≈-104.5%
≈-104.5%
-13.7%
Weak
Financial Health
Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
STIM
5Y avg
Peer Median
Verdict
Debt / Equity (MRQ)
3.45Y avg ≈1.5
≈1.5
0.4
High debt
Current Ratio (MRQ)
1.95Y avg ≈3.8
≈3.8
2.3
Below avg
Quick Ratio
1.55Y avg ≈3.1
≈3.1
1.5
In line
Long-Term Debt / Equity (MRQ)
3.45Y avg ≈1.5
≈1.5
·
·
Growth
Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
STIM
5Y avg
Peer Median
Verdict
Revenue YoY
99.2%5Y avg ≈28.8%
≈28.8%
·
·
Revenue CAGR 3Y
31.8%5Y avg ≈18.5%
≈18.5%
·
·
Revenue CAGR 5Y
24.8%
·
·
·
Per Share Metrics
EPS, book value per share, cash flow per share, dividend per share
Metric
5Y trend
STIM
5Y avg
Peer Median
Verdict
EPS (Diluted)
$-0.595Y avg ≈$-1.12
≈$-1.12
·
·
Revenue / Share
$2.265Y avg ≈$2.34
≈$2.34
·
·
Cash Flow / Share
$-0.315Y avg ≈$-0.93
≈$-0.93
·
·
Cash / Share
$0.415Y avg ≈$1.79
≈$1.79
·
·
Capital Efficiency
Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
STIM
5Y avg
Peer Median
Verdict
Asset Turnover
1.15Y avg ≈0.7
≈0.7
1.1
In line
Inventory Turnover
17.95Y avg ≈5.6
≈5.6
3.5
Top tier
Receivables Turnover
7.55Y avg ≈5.9
≈5.9
6.0
Top tier
Revenue / Employee
≈$226.7K
·
·
·
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History
EPS actual vs estimate, surprise %, beat rate, next earnings date
14
Avg Surprise-11.0%
Next ReportNov 02, 2026
Period
Report
EPS Actual
EPS Est
Surprise
June 30, 2026
Aug 3, 2026
$-0.04
$-0.12
68.0%
March 31, 2026
May 12, 2026
$-0.15
$-0.18
15.2%
Dec. 31, 2025
$-0.10
$-0.11
8.1%
Sept. 30, 2025
$-0.13
$-0.13
-0.62%
June 30, 2025
$-0.15
$-0.08
-91.8%
March 31, 2025
$-0.21
$-0.13
-64.7%
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
15
Income Statement16
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
$149M
$75M
$71M
$65M
$55M
$49M
$63M
$53M
$40M
Cost of Revenue
$77M
$21M
$20M
$15M
$12M
$12M
$15M
$12M
$10M
Gross Profit
$72M
$54M
$52M
$50M
$44M
$38M
$47M
$40M
$31M
R&D Expense
$7M
$13M
$10M
$9M
$8M
$9M
$14M
$8M
$8M
SG&A Expense
$50M
$30M
$25M
$26M
$26M
$18M
$17M
$14M
$9M
Operating Expenses
$104M
$89M
$82M
$85M
$71M
$60M
$74M
$60M
$44M
Operating Income
$-31M
$-35M
$-31M
$-35M
$-28M
$-22M
$-27M
$-20M
$-14M
Interest Expense
·
$7M
$5M
$4M
$4M
$5M
$4M
$4M
$3M
Other Non-op
$716.0K
$3M
$6M
$2M
$390.0K
$302.0K
$2M
$-575.0K
$357.0K
Pretax Income
·
·
·
·
·
·
$-29M
$-24M
$-16M
Net Income
$-39M
$-44M
$-30M
$-37M
$-31M
$-27M
$-29M
$-24M
$-16M
EPS (Basic)
$-0.59
$-1.38
$-1.05
$-1.38
$-1.22
$-1.46
$-1.58
·
·
EPS (Diluted)
$-0.59
$-1.38
$-1.05
$-1.38
$-1.22
$-1.46
$-1.58
·
·
Shares (Basic)
65,951,000
31,734,000
28,658,000
26,900,000
25,479,000
18,835,000
18,380,000
·
·
Shares (Diluted)
65,951,000
31,734,000
28,658,000
26,900,000
25,479,000
18,835,000
18,380,000
·
·
EBITDA
$-28M
$-32M
$-29M
$-33M
$-27M
$-21M
$-26M
$-19M
·
Balance Sheet24
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Cash & Equivalents
$28M
$18M
$60M
$70M
$94M
$49M
$76M
$105M
$29M
Receivables
$16M
$23M
$16M
$14M
$8M
$7M
$7M
$6M
$4M
Inventory
$4M
$4M
$8M
$9M
$7M
$4M
$3M
$2M
$2M
Prepaid Expense
$3M
$7M
$5M
$2M
$3M
$2M
$2M
$2M
$1M
Current Assets
$62M
$58M
$94M
$99M
$115M
$65M
$88M
$114M
$37M
PP&E (Net)
$4M
$6M
$2M
$2M
$1M
$730.0K
$1M
$1M
$1M
PP&E (Gross)
$9M
$9M
$5M
$5M
$4M
$3M
$3M
$3M
$3M
Accum. Depreciation
$4M
$3M
$3M
$3M
$3M
$2M
$2M
$2M
$2M
Goodwill
$24M
$19M
·
·
·
·
·
·
·
Intangibles
$18M
$20M
·
·
·
·
·
·
·
Other Non-current Assets
$2M
$2M
$4M
$4M
$2M
$2M
$1M
$1M
$574.0K
Total Assets
$142M
$141M
$116M
$117M
$141M
$79M
$100M
$117M
$39M
Accounts Payable
$11M
$11M
$5M
$2M
$4M
$4M
$5M
$4M
$3M
Accrued Liabilities
$12M
$13M
$13M
$15M
$8M
$7M
$9M
$8M
$8M
Current Liabilities
$31M
$31M
$20M
$33M
$16M
$14M
$28M
$14M
$12M
Capital Leases
$19M
$23M
$2M
$3M
$4M
$3M
$3M
·
·
Total Liabilities
$115M
$109M
$82M
$60M
$56M
$53M
$52M
$46M
$44M
Long-term Debt
$66M
$55M
$59M
$36M
$35M
$35M
$31M
$30M
$30M
Total Debt
$66M
$55M
$59M
$36M
$35M
$35M
$31M
$30M
·
Common Stock
$690.0K
$557.0K
$291.0K
$273.0K
$264.0K
$191.0K
$186.0K
$177.0K
$2.0K
Retained Earnings
$-459M
$-420M
$-376M
$-346M
$-309M
$-278M
$-250M
$-221M
$-197M
Stockholders' Equity
$22M
$28M
$34M
$57M
$85M
$25M
$48M
$71M
$-193M
Liabilities + Equity
$142M
$141M
$116M
$117M
$141M
$79M
$100M
$117M
$39M
Shares Outstanding
68,994,000
55,679,000
29,092,000
27,268,000
26,395,000
19,114,000
18,645,000
17,744,000
231,000
Cash Flow14
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
D&A
$3M
$2M
$2M
$2M
$1M
$941.0K
$1M
$882.0K
$596.0K
Stock-based Comp
$7M
$6M
$7M
$9M
$8M
$4M
$3M
$2M
$496.0K
Deferred Tax
$0
$0
$0
$0
$0
$0
$0
$0
$0
Amort. of Intangibles
$2M
$100.0K
·
·
·
·
·
·
·
Other Non-cash
$8M
$5M
$-11M
$-4M
$-6M
$-6M
$-6M
$881.0K
·
Operating Cash Flow
$-20M
$-31M
$-32M
$-31M
$-28M
$-28M
$-30M
$-21M
$-11M
CapEx
$801.0K
$1M
$2M
$3M
$2M
$730.0K
$813.0K
$1M
$594.0K
Investing Cash Flow
$-801.0K
$-2M
$-1M
$7M
$-10M
$-730.0K
$-813.0K
$-1M
$-594.0K
Debt Issued
$10M
$57M
$25M
·
·
$41M
·
·
·
Net Debt Issued
$10M
$-3M
$24M
·
·
$2M
·
·
·
Stock Issued
·
·
·
·
$81M
·
·
·
·
Net Stock Activity
·
·
·
·
$81M
·
·
·
·
Financing Cash Flow
$36M
$-7M
$23M
$207.0K
$83M
$2M
$2M
$97M
$24M
Free Cash Flow
$-21M
$-32M
$-34M
$-34M
$-30M
$-29M
$-31M
$-22M
·
Profitability7
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Gross Margin
48.5%
72.3%
72.5%
76.3%
78.9%
·
·
76.4%
·
Operating Margin
-21.1%
-46.2%
-42.8%
-53.8%
-49.8%
·
·
-37.6%
·
Net Margin
-26.2%
-58.4%
-42.3%
-57.0%
-56.4%
·
·
-45.7%
·
Pretax Margin
·
·
·
·
·
·
·
-45.7%
·
EBITDA Margin
-18.8%
-43.4%
-40.0%
-51.3%
-47.9%
·
·
-35.9%
·
ROA
-27.6%
-34.1%
-25.9%
-28.8%
-28.4%
-30.7%
-26.8%
-30.9%
·
ROE
-155.7%
-185.6%
-83.7%
-61.9%
-35.4%
-103.6%
-56.9%
-32.7%
·
Liquidity & Solvency5
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Current Ratio
2.0
1.9
4.7
3.0
7.3
4.8
3.2
8.4
·
Quick Ratio
1.5
1.3
3.8
2.5
6.5
4.1
3.0
8.1
·
Debt / Equity
2.9
2.0
1.7
0.6
0.4
1.4
0.7
0.4
·
LT Debt / Equity
2.9
2.0
1.7
0.4
0.4
1.4
0.4
0.4
·
Interest Coverage
·
-4.7
-5.6
-8.3
-6.9
-4.9
-7.3
-5.4
·
Efficiency3
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Asset Turnover
1.1
0.6
0.6
0.5
0.5
·
·
0.7
·
Inventory Turnover
17.9
3.4
2.3
2.0
2.3
3.6
5.9
5.1
·
Receivables Turnover
7.5
3.8
4.9
6.1
7.4
·
·
10.7
·
Per Share5
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Book Value / Share
$0.32
$0.50
$1.18
$2.09
$3.23
$1.33
$2.57
$4.00
·
Revenue / Share
$2.26
$2.36
$2.49
$2.42
$2.17
·
·
·
·
Cash Flow / Share
$-0.31
$-0.98
$-1.12
$-1.14
$-1.10
·
·
·
·
Cash / Share
$0.41
$0.33
$2.05
$2.58
$3.57
$2.56
$4.06
$5.89
·
EPS (TTM)
$-0.59
$-1.38
$-1.05
$-1.38
$-1.22
$-1.46
$-1.58
·
·
Growth Rates3
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue YoY
99.2%
5.0%
9.4%
17.9%
12.3%
·
·
·
·
Revenue CAGR 3Y
31.8%
10.6%
13.2%
·
·
·
·
·
·
Revenue CAGR 5Y
24.8%
·
·
·
·
·
·
·
·
Valuation (TTM)14
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue TTM
$149M
$75M
$71M
$65M
$55M
$49M
$63M
$53M
·
Net Income TTM
$-39M
$-44M
$-30M
$-37M
$-31M
$-27M
$-29M
$-24M
·
Market Cap
$95M
$90M
$84M
$187M
$118M
$212M
$84M
$343M
·
Enterprise Value
$133M
$126M
$84M
$153M
$59M
$198M
$39M
$269M
·
P/E
-2.3
-1.2
-2.8
-5.0
-3.7
-7.6
-2.8
·
·
P/S
0.6
1.2
1.2
2.9
2.1
4.3
1.3
6.5
·
P/B
4.3
3.2
2.5
3.3
1.4
8.3
1.7
4.8
·
P / Tangible Book
·
·
2.5
3.3
1.4
8.3
·
·
·
P / Cash Flow
-4.7
-2.9
-2.6
-6.1
-4.2
-7.5
-2.7
-16.7
·
P / FCF
-4.5
-2.8
-2.5
-5.5
-3.9
-7.3
-2.7
-15.9
·
EV / EBITDA
-4.8
-3.9
-2.9
-4.6
-2.2
-9.3
-1.5
-14.2
·
EV / FCF
-6.3
-3.9
-2.4
-4.5
-1.9
-6.8
-1.3
-12.5
·
EV / Revenue
0.9
1.7
1.2
2.3
1.1
4.0
0.6
5.1
·
Earnings Yield
-42.8%
-85.7%
-36.2%
-20.1%
-27.4%
-13.1%
-35.2%
·
·
Income Statement15
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Revenue
$42M
$34M
$42M
$37M
$38M
$32M
$22M
$19M
$16M
$17M
$20M
$18M
$18M
$16M
$18M
$16M
Cost of Revenue
$20M
$18M
$20M
$20M
$20M
$16M
$8M
$5M
$4M
$4M
$5M
$6M
$5M
$4M
$4M
$4M
Gross Profit
$21M
$16M
$22M
$17M
$18M
$16M
$15M
$14M
$12M
$13M
$16M
$12M
$13M
$11M
$14M
$13M
R&D Expense
$1M
$1M
$2M
$2M
$2M
$2M
$6M
$2M
$2M
$2M
$2M
$2M
$2M
$3M
$3M
$2M
SG&A Expense
$11M
$13M
$13M
$11M
$12M
$13M
$11M
$7M
$6M
$6M
$6M
$6M
$6M
$7M
$6M
$6M
Operating Expenses
$23M
$25M
$27M
$24M
$26M
$27M
$26M
$22M
$21M
$20M
$20M
$21M
$20M
$21M
$22M
$20M
Operating Income
$-2M
$-9M
$-5M
$-7M
$-8M
$-11M
$-11M
$-8M
$-9M
$-7M
$-4M
$-9M
$-7M
$-10M
$-8M
$-7M
Interest Expense
$2M
$2M
·
$2M
$2M
$2M
·
$2M
$2M
$2M
·
$1M
$1M
$1M
$1M
$1M
Other Non-op
$162.0K
$1M
$155.0K
$126.0K
$188.0K
$247.0K
$545.0K
$539.0K
$653.0K
$812.0K
$893.0K
$664.0K
$4M
$640.0K
$648.0K
$906.0K
Net Income
$-3M
$-11M
$-7M
$-9M
$-10M
$-13M
$-13M
$-13M
$-10M
$-8M
$-5M
$-9M
$-5M
$-11M
$-8M
$-8M
EPS (Basic)
$-0.05
$-0.16
$-0.10
$-0.13
$-0.15
$-0.21
$-0.34
$-0.44
$-0.33
$-0.27
$-0.17
$-0.33
$-0.17
$-0.38
$-0.30
$-0.28
EPS (Diluted)
$-0.05
$-0.16
$-0.10
$-0.13
$-0.15
$-0.21
$-0.34
$-0.44
$-0.33
$-0.27
$-0.17
$-0.33
$-0.17
$-0.38
$-0.30
$-0.28
Shares (Basic)
73,129,000
69,589,000
·
67,309,000
66,180,000
61,465,000
·
30,267,000
30,052,000
29,472,000
·
28,876,000
28,590,000
28,034,000
·
26,965,000
Shares (Diluted)
73,129,000
69,589,000
·
67,309,000
66,180,000
61,465,000
·
30,267,000
30,052,000
29,472,000
·
28,876,000
28,590,000
28,034,000
·
26,965,000
EBITDA
·
$-8M
·
$-7M
$-8M
$-10M
·
$-8M
$-9M
$-6M
·
$-9M
$-7M
$-9M
·
$-7M
Balance Sheet25
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Cash & Equivalents
$19M
$13M
$28M
$28M
$11M
$20M
$18M
$21M
$43M
$48M
$60M
$36M
$46M
$55M
$70M
$74M
Receivables
$16M
$16M
$16M
$19M
$26M
$26M
$23M
$17M
$17M
$18M
·
$15M
$13M
$9M
·
$12M
Inventory
$6M
$5M
$4M
$4M
$5M
$4M
$4M
$5M
$6M
$7M
·
$10M
$9M
$9M
·
$9M
Prepaid Expense
$4M
$4M
$3M
$4M
$4M
$5M
$7M
$5M
$4M
$4M
·
$5M
$5M
$2M
·
$3M
Current Assets
$53M
$47M
$62M
$65M
$56M
$61M
$58M
$53M
$76M
$82M
·
$71M
$78M
$81M
·
$101M
PP&E (Net)
$3M
$4M
$4M
$5M
$5M
$6M
$6M
$2M
$2M
$2M
·
$2M
$2M
$2M
·
$2M
PP&E (Gross)
$7M
$8M
$9M
$9M
$9M
$9M
$9M
$5M
$5M
$5M
·
$6M
$5M
$5M
·
$5M
Accum. Depreciation
$4M
$4M
$4M
$4M
$4M
$4M
$3M
$3M
$3M
$3M
·
$4M
$3M
$3M
·
$3M
Goodwill
$24M
$24M
$24M
$23M
$19M
$19M
$19M
·
·
·
·
·
·
·
·
·
Intangibles
$17M
$18M
$18M
$19M
$19M
$19M
$20M
·
·
·
·
·
·
·
·
·
Other Non-current Assets
$3M
$2M
$2M
$2M
$2M
$2M
$2M
$5M
$5M
$5M
·
$4M
$4M
$3M
·
$4M
Total Assets
$132M
$125M
$142M
$145M
$135M
$142M
$141M
$74M
$97M
$104M
·
$93M
$100M
$104M
·
$119M
Accounts Payable
$12M
$11M
$11M
$12M
$10M
$8M
$11M
$3M
$4M
$3M
·
$3M
$4M
$5M
·
$2M
Accrued Liabilities
$9M
$10M
$12M
$10M
$11M
$9M
$13M
$11M
$9M
$9M
·
$10M
$8M
$7M
·
$11M
Current Liabilities
$28M
$28M
$31M
$29M
$28M
$25M
$31M
$17M
$29M
$14M
·
$15M
$15M
$15M
·
$25M
Capital Leases
$20M
$19M
$19M
$19M
$20M
$22M
$23M
$2M
$2M
$2M
·
$3M
$3M
$3M
·
$3M
Other Non-current Liabilities
$142.0K
$71.0K
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Total Liabilities
$110M
$108M
$115M
$114M
$103M
$102M
$109M
$65M
$77M
$76M
·
$55M
$55M
$55M
·
$56M
Long-term Debt
$62M
$61M
$66M
$66M
$56M
$55M
$55M
$46M
$60M
$59M
·
$37M
$37M
$37M
·
$36M
Total Debt
·
$61M
·
$66M
$56M
$55M
·
$46M
$60M
$59M
·
$37M
$37M
$37M
·
$36M
Common Stock
$762.0K
$696.0K
$690.0K
$685.0K
$661.0K
$658.0K
$557.0K
$303.0K
$301.0K
$300.0K
·
$289.0K
$288.0K
$285.0K
·
$270.0K
Retained Earnings
$-473M
$-470M
$-459M
$-452M
$-443M
$-432M
$-420M
$-407M
$-394M
$-384M
·
$-371M
$-361M
$-356M
·
$-338M
Stockholders' Equity
$18M
$13M
$22M
$27M
$27M
$35M
$28M
$9M
$19M
$28M
·
$38M
$45M
$48M
·
$63M
Liabilities + Equity
$132M
$125M
$142M
$145M
$135M
$142M
$141M
$74M
$97M
$104M
·
$93M
$100M
$104M
·
$119M
Shares Outstanding
76,193,000
69,583,000
68,994,000
68,445,000
66,113,000
65,820,000
55,679,000
30,317,000
30,136,000
29,975,000
·
28,902,000
28,813,000
28,465,000
·
27,060,000
Cash Flow13
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
D&A
$729.0K
$745.0K
$767.0K
$886.0K
$901.0K
$911.0K
$446.0K
$512.0K
$555.0K
$560.0K
$503.0K
$499.0K
$488.0K
$516.0K
$604.0K
$387.0K
Stock-based Comp
$688.0K
$2M
$2M
$1M
$2M
$1M
$1M
$1M
$2M
$1M
$2M
$2M
$2M
$2M
$2M
$2M
Amort. of Intangibles
$400.0K
$400.0K
$300.0K
$400.0K
$400.0K
$400.0K
$100.0K
$0
$0
$0
·
·
·
·
·
·
Other Non-cash
·
$-1M
·
·
·
$-7M
·
·
·
$-6M
·
·
·
$-7M
·
·
Operating Cash Flow
$-1M
$-9M
$908.0K
$-785.0K
$-4M
$-17M
$-9M
$-5M
$-5M
$-12M
$2M
$-10M
$-9M
$-15M
$-3M
$-7M
CapEx
$417.0K
$197.0K
$216.0K
$114.0K
$252.0K
$219.0K
$89.0K
$386.0K
$616.0K
$375.0K
$879.0K
$552.0K
$704.0K
$234.0K
$503.0K
$726.0K
Investing Cash Flow
$-417.0K
$-172.0K
$-216.0K
$-114.0K
$-252.0K
$-219.0K
$-2M
$14.0K
$-119.0K
$68.0K
$-563.0K
$66.0K
$-642.0K
$-183.0K
$-503.0K
$9M
Debt Issued
·
·
$0
·
·
·
$9M
·
·
·
$22M
$0
$0
$2M
·
·
Net Debt Issued
·
$-5M
·
·
·
·
·
·
·
·
·
·
·
$1M
·
·
Stock Issued
·
·
·
·
$0
$21M
·
·
·
·
·
·
·
·
·
·
Net Stock Activity
·
·
·
·
·
$21M
·
·
·
·
·
·
·
·
·
·
Financing Cash Flow
$7M
$-6M
$-1M
$18M
$1.0K
$19M
$10M
·
·
·
$22M
$0
$-62.0K
$499.0K
$245.0K
$0
Free Cash Flow
·
$-10M
·
·
·
$-17M
·
·
·
$-12M
·
·
·
$-15M
·
·
Profitability6
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Gross Margin
·
46.9%
·
45.9%
46.6%
49.2%
·
75.6%
74.0%
75.1%
·
65.8%
72.5%
73.3%
·
78.4%
Operating Margin
·
-26.1%
·
-19.6%
-21.1%
-34.4%
·
-41.7%
-51.7%
-39.4%
·
-49.6%
-41.7%
-63.7%
·
-45.2%
Net Margin
·
-31.3%
·
-24.2%
-26.6%
-39.6%
·
-72.0%
-59.8%
-45.2%
·
-52.5%
-27.8%
-67.7%
·
-46.1%
EBITDA Margin
·
-23.9%
·
-19.6%
-21.1%
-31.6%
·
-41.7%
-51.7%
-36.2%
·
-49.6%
-41.7%
-60.4%
·
-45.2%
ROA
·
-8.1%
·
-8.2%
-8.7%
-10.3%
·
-16.0%
-10.0%
-7.6%
·
-8.8%
-4.4%
-9.0%
·
-5.8%
ROE
·
-44.3%
·
-49.2%
-43.5%
-40.2%
·
-56.4%
-30.3%
-20.7%
·
-18.6%
-8.6%
-16.8%
·
-9.9%
Liquidity & Solvency5
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Current Ratio
·
1.7
·
2.2
2.0
2.4
·
3.2
2.6
5.6
·
4.6
5.2
5.4
·
4.0
Quick Ratio
·
1.0
·
1.6
1.3
1.9
·
2.2
2.0
4.5
·
3.3
3.9
4.3
·
3.4
Debt / Equity
·
4.6
·
2.4
2.0
1.6
·
4.9
3.1
2.1
·
1.0
0.8
0.8
·
0.6
LT Debt / Equity
·
4.6
·
2.4
2.0
1.6
·
4.9
2.4
2.1
·
1.0
0.8
0.8
·
0.4
Interest Coverage
·
-4.0
·
-3.3
-4.1
-5.7
·
-4.5
-4.3
-3.8
·
-7.5
-6.4
-7.9
·
-7.0
Efficiency3
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Asset Turnover
·
0.3
·
0.3
0.3
0.3
·
0.2
0.2
0.2
·
0.2
0.2
0.1
·
0.1
Inventory Turnover
·
4.2
·
4.4
3.7
3.0
·
0.6
0.6
0.5
·
0.7
0.6
0.5
·
0.5
Receivables Turnover
·
1.6
·
2.1
1.8
1.5
·
1.2
1.1
1.3
·
1.3
1.4
1.8
·
1.7
Per Share5
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Book Value / Share
·
$0.19
·
$0.40
$0.41
$0.54
·
$0.31
$0.64
$0.92
·
$1.31
$1.58
$1.70
·
$2.33
Revenue / Share
·
$0.50
·
$0.55
$0.58
$0.52
·
$0.61
$0.55
$0.59
·
$0.62
$0.62
$0.55
·
$0.61
Cash Flow / Share
·
$-0.14
·
·
·
$-0.28
·
·
·
$-0.41
·
·
·
$-0.54
·
·
Cash / Share
·
$0.19
·
$0.41
$0.17
$0.31
·
$0.69
$1.42
$1.59
·
$1.24
$1.59
$1.95
·
$2.72
EPS (TTM)
$-0.49
$-0.54
·
$-0.83
$-1.14
$-1.32
·
$-1.21
$-1.10
$-0.94
·
$-1.18
$-1.13
$-1.35
·
$-1.39
Valuation (TTM)11
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Revenue TTM
$151M
$152M
·
$130M
$111M
$89M
·
$73M
$72M
$73M
·
$69M
$68M
$67M
·
$62M
Net Income TTM
$-33M
$-37M
·
$-45M
$-49M
$-49M
·
$-36M
$-32M
$-28M
·
$-33M
$-31M
$-37M
·
$-37M
Market Cap
·
$101M
·
$187M
$231M
$242M
·
$23M
$54M
$143M
·
$39M
$62M
$83M
·
$86M
Enterprise Value
·
$149M
·
$225M
$275M
$277M
·
$48M
$71M
$154M
·
$40M
$53M
$64M
·
$48M
P/E
-2.7
-2.7
·
-3.3
-3.1
-2.8
·
-0.6
-1.6
-5.1
·
-1.1
-1.9
-2.2
·
-2.3
P/S
·
0.7
·
1.4
2.1
2.7
·
0.3
0.8
1.9
·
0.6
0.9
1.2
·
1.4
P/B
·
7.6
·
6.8
8.5
6.8
·
2.5
2.8
5.2
·
1.0
1.4
1.7
·
1.4
P / Tangible Book
·
·
·
·
·
·
·
2.5
2.8
5.2
·
1.0
1.4
1.7
·
1.4
P / Cash Flow
·
-10.7
·
·
·
-14.3
·
·
·
-11.9
·
·
·
-5.4
·
·
EV / Revenue
·
1.0
·
1.7
2.5
3.1
·
0.7
1.0
2.1
·
0.6
0.8
1.0
·
0.8
Earnings Yield
-33.9%
-37.2%
·
-30.4%
-32.7%
-35.9%
·
-159.2%
-61.1%
-19.8%
·
-87.4%
-52.6%
-46.4%
·
-43.7%
Most recent period on the left · null values shown as ·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
16
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Revenue
$149M
$75M
$71M
$65M
$55M
Gross Margin %
48.5%
72.3%
72.5%
76.3%
78.9%
Operating Margin %
-21.1%
-46.2%
-42.8%
-53.8%
-49.8%
Net Income
$-39M
$-44M
$-30M
$-37M
$-31M
Diluted EPS
$-0.59
$-1.38
$-1.05
$-1.38
$-1.22
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Debt / Equity
2.9
2.0
1.7
0.6
0.4
Current Ratio
2.0
1.9
4.7
3.0
7.3
Quick Ratio
1.5
1.3
3.8
2.5
6.5
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Free Cash Flow
$-21M
$-32M
$-34M
$-34M
$-30M
Institutional owners (13F)
99 filers
· $52.4M total
· As of June 30, 2026
17
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders99
Value held$52.4M
New positions17
Exited positions28
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
17 (-12 vs prior Q)
28 (+6 vs prior Q)
30 (+5 vs prior Q)
25 (0 vs prior Q)
-4.3M
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
MADRYN ASSET MANAGEMENT, LP, MADRYN HEALTH PARTNERS II, LP, MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP, MADRYN HEALTH ADVISORS II, LP, MADRYN HEALTH ADVISORS GP II, LLC, MADRYN SELECT OPPORTUNITIES, LP, MADRYN SELECT ADVISORS, LP, MADRYN SELECT ADVISORS GP, LLC
×3 filings
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders
29 insiders
· 9 officers · 14 directors